Private Equity Investment in Clinical Trial Sites Raises Potential Antitrust, CPOM Concerns

Private equity’s growing interest in clinical trial sites and services raises questions about how increased consolidation will impact the cost and sustainability of pharmaceutical research and development (R&D), and this trend could implicate both antitrust law and state Corporate Practice of Medicine (CPOM) doctrines, sources told The Capitol Forum. “Clinical trial sites are a critical […]

House Judiciary Panel Counsel Cella, Paul Hastings Partner Murray Emerge as Early Contenders to Become DOJ Antitrust Head

Adam Cella, a senior House GOP counsel, and Michael Murray, who served at DOJ during President Donald Trump’s first term, have emerged as early contenders to take over the department’s antitrust...

Apr 20, 2026 Read Now >

European Proposals for Social Media Bans Create Pressure on VPNs

Plans to restrict children’s access to social media have been sprouting around Europe in the last few months, raising questions about whether kids could easily get around such bans. The attention...

Apr 16, 2026 Read Now >

IonQ/SkyWater: Quantum Computing Tie-up Draws Industry Questions Over Foundry Access, Information Firewalls, But DOD Support Could Ease Antitrust Path

Quantum computing chipmaker IonQ’s (IONQ) pending $1.8 billion acquisition of specialty foundry SkyWater Technology (SKYT) raises red flags about post-merger access...

Apr 16, 2026 Read Now >

Private Equity Investment in Clinical Trial Sites Raises Potential Antitrust, CPOM Concerns

RELATED ARTICLES | Editor’s picks

House Judiciary Panel Counsel Cella, Paul Hastings Partner Murray Emerge as Early Contenders to Become DOJ Antitrust Head

European Proposals for Social Media Bans Create Pressure on VPNs

IonQ/SkyWater: Quantum Computing Tie-up Draws Industry Questions Over Foundry Access, Information Firewalls, But DOD Support Could Ease Antitrust Path

FILTER BY

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.